l. University of Minnesota reports 183 new EBOV cases in West Africa between 13 February and 16 February, including 100 EBOV deaths. See: http://www.cidrap.umn.edu/news-perspective/2015/02/cases-ebola-outbreak-region-top-23000
2. WorldBulletin reports that Liberian vaccine trial participants are being stigmatized (excluded by friends for 21 days) after they receive their vaccination (or placebo). The PREVAIL vaccine trials are being conducted in Liberia. See: http://www.worldbulletin.net/news/155149/liberians-stigmatized-for-taking-ebola-trial-vaccine.
3. Wall Street Journal reports on several new rapid PCR diagnostic tests for EBOV, TB, cholera. The reporter calls these rapid diagnostic tests the ‘silver lining’ in EBOV epidemic. See: http://www.wsj.com/articles/how-to-detect-infectious-diseases-like-ebola-faster-1424145643
4. Chemistry World (journal of Royal Society of Chemistry) reports on a nanoparticle ‘paper’ that performs ‘dipstick’ test for dengue, Yellow Fever, and EBOV simultaneously. See: http://www.rsc.org/chemistryworld/2015/02/paper-test-ebola-dengue-yellow-fever-silver-nanoparticles
5. Journal of Infectious Disease 15 February has Correspondence from Fedson re: effectiveness of statins in reducing the mortality of EBOV. Statins not only reduce LDL, but also maintain endothelial pathways and coagulation pathways. See: https://col128.mail.live.com/mail/ViewOfficePreview.aspx?messageid=mgVFbi8aC25BGU2hBgS6DZlg2&folderid=flsent&attindex=0&cp=-1&attdepth=0&n=6438344
6. A non-EBOV article appeared in The Record, the daily science report from Washington University in St. Louis re: passage of maternal traits to offspring via bacterial DNA. See the detailed explanation for the Wash U. community at: https://news.wustl.edu/news/Pages/mothers-can-pass-traits-to-offspring-through-bacterias-DNA.aspx.